glp-1 obesity drug news today 2025 therapies are changing care. What does WHO recommend? Here's what you need to know obesity drug news today october

Sources Adquey FDA approval letter Adquey (difamilast) 02/12/2026 Acrotech Biopharma press release Adquey (difamilast) 02/13/2026 FDA prescribing information Bysanti (milsaperidone) Vanda Pharmaceuticals press release Bysanti (milsaperidone) 02/20/2026 Immedica press release Loargys 02/23/2026 PEACE trial ( NCT03921541 ) Prescribing information Yuviwel (navepegritide) Ascendis Pharma press release Yuviwel 02/27/2026

High-dose B-complex and vitamin C are known irritants that can cause nausea when infused at faster rates

No product benefit claim should be made without appropriate evidence

Selected Research References Garvey WT, Blher M, Kushner RF, et al